Pharmaceutical manufacturing company in Jordan

id - 240
icon
Jordan
Pharmaceuticals
Views: 270
  • Pharmaceutical manufacturing company in Jordan
  • Pharmaceutical manufacturing company in Jordan
    Pharmaceutical manufacturing company in Jordan
  • Revenue (year) 37,000,000 $
    2,971,703,100 ₽
    Profit (year) 6,300,000 $
    505,992,690 ₽
    Payback (mon.)
    Description

    The pharmaceutical manufacturing company, located in Jordan, is for sale. This company was founded around 40 year ago in Amman, Jordan, and now is presented in more than 20 countries of MENA region. It holds the regional benchmark in innovation with more than 70 patents.

    As direct result of this innovation, operations were diversified outside the traditional generic pharmaceutical industry by spinning out mature technology platforms into subsidiaries with independent management and resources.

    Products:

    Products cover a wide range of therapeutic categories including the cardiovascular, gastrointestinal, central nervous system, anti-infective, endocrine, musculo-skeletal, respiratory, obstetric, gynecology & urinary tract, and immune systems.

    Natural Products:

    It is renowned as the one of the best company in the Middle East specializing in the development and production of plant and herbal medical products from standardized medicinal plant extracts, offering more than 50 natural and herbal innovative products with business operations in more than 20 countries worldwide.

    Biotechnology:

    It is a developer and producer of proprietary biotechnology healthcare products that specializes in the production.

    Pharmaceutical Business:

    It offers more than 200 pharmaceutical products that cover the needs of consumers and healthcare professionals. These products include tablets, capsules, suppositories, syrups and suspensions, which are manufactured in accordance with Good Manufacturing Practices (GMP). The company has a competitive advantage that makes it one of the leading pharmaceutical companies, as its products are of high quality.

    Directions:

    1. Core branded generic pharmaceutical business.
    2. Natural products through the subsidiary.
    3. Biotech diagnostics through the subsidiary.
    4. Novel excipients and drug delivery systems through the subsidiary.

    To obtain the details, the potential buyer must sign the NDA and send the POF.

    The information in the catalog is not an exact offer. The parameters of the deal are specified during negotiations with the seller.

    To perform this action, you must log in or register on the site.
    Start negotiation
    Price
    45,000,000 $
    3,614,233,500 ₽
    To perform this action, you must log in or register on the site.
    Start negotiation
    icon Useful tip

    Interested in an ad in the catalog? To avoid losing it and easily find it in the future, add it to "Favorites". To do this, click the heart icon in the upper right corner of the card or ad page.

    Similar adverts
    icon
    Kyrgyzstan
    Medicine production plant in Kyrgyzstan Medicine production plant in Kyrgyzstan
    Audit done
    Revenue (year)
    No data
    Profit (year)
    No data
    Payback (mon.)
    Price
    6,000,000 €
    551,250,600 ₽
    icon
    Kazakhstan
    Pharmaceutical production in western Kazakhstan Pharmaceutical production in western Kazakhstan
    Revenue (year)
    No data
    Profit (year)
    No data
    Payback (mon.)
    Price
    3,000,000,000 ₸
    441,009,000 ₽
    icon
    India
    Pharmaceutical company in India Pharmaceutical company in India
    Revenue (year)
    306,500,000 $
    24,616,945,950 ₽
    Profit (year)
    87,500,000 $
    7,027,676,250 ₽
    Payback (mon.)
    Price
    1,050,000,000 $
    84,332,115,000 ₽
    Currency rates calculator
    Contact REAB
    Contact REAB
    Messengers for this number